Zorvolex (Iroko Pharmaceuticals LLC)


Welcome to the PulseAid listing for the Zorvolex drug offered from Iroko Pharmaceuticals LLC. This Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Iroko Pharmaceuticals LLC
NON-PROPRIETARY NAME: diclofenac
SUBSTANCE NAME: DICLOFENAC
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2013-10-31
END MARKETING DATE: 0000-00-00


Zorvolex HUMAN PRESCRIPTION DRUG Details:

Item DescriptionZorvolex from Iroko Pharmaceuticals LLC
LABELER NAME: Iroko Pharmaceuticals LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 18(mg/1)
START MARKETING DATE: 2013-10-31
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42211-203_e2d6204c-751c-4ecf-beca-bf7b79bd75a6
PRODUCT NDC: 42211-203
APPLICATION NUMBER: NDA204592

Other DICLOFENAC Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Iroko Pharmaceuticals LLCZorvolex